257 related articles for article (PubMed ID: 7519153)
1. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
Dgani R; Zalel Y; Biran H; Blickstein I; Caspi B; Weissman A; Shoham Z
Eur J Obstet Gynecol Reprod Biol; 1994 Mar; 54(1):77-9. PubMed ID: 7519153
[TBL] [Abstract][Full Text] [Related]
2. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
3. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
4. Gestational trophoblastic disease.
Hammond CB; Olt GJ
Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
[No Abstract] [Full Text] [Related]
5. Recurrent gestational trophoblastic disease following in-vitro fertilization.
Tanos V; Meirow D; Reubinoff BE; Anteby SO
Hum Reprod; 1994 Nov; 9(11):2010-3. PubMed ID: 7532652
[TBL] [Abstract][Full Text] [Related]
6. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
7. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
8. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
9. Invasive mole.
Franke HR; Vermorken JB; von Kessel H; Dijkhuizen GH; Calame JJ; Stolk JG
Eur J Obstet Gynecol Reprod Biol; 1986 Mar; 21(3):181-5. PubMed ID: 3007229
[TBL] [Abstract][Full Text] [Related]
10. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
[TBL] [Abstract][Full Text] [Related]
11. [Gestational trophoblastic tumors and recent clinical information].
Shimizu T; Yaegashi N
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1363-70. PubMed ID: 12214462
[TBL] [Abstract][Full Text] [Related]
12. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
Laan R; Bakker P; Lammes FB
Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506
[TBL] [Abstract][Full Text] [Related]
14. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
15. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989.
Newlands ES; Bagshawe KD; Begent RH; Rustin GJ; Holden L
Br J Obstet Gynaecol; 1991 Jun; 98(6):550-7. PubMed ID: 1651757
[TBL] [Abstract][Full Text] [Related]
16. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
17. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Rattanaburi A; Boonyapipat S; Supasinth Y
Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637
[TBL] [Abstract][Full Text] [Related]
18. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases.
Zalel Y; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):67-71. PubMed ID: 9031962
[TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
[TBL] [Abstract][Full Text] [Related]
20. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
Lurain JR; Brewer JI
Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]